Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,783 | 409 | 99.4% |
| Education | $32.53 | 4 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,309 | 82 | $0 (2022) |
| Novo Nordisk Inc | $909.08 | 68 | $0 (2022) |
| GlaxoSmithKline, LLC. | $887.13 | 74 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $748.27 | 47 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $278.47 | 20 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $274.68 | 20 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $214.74 | 13 | $0 (2019) |
| Lilly USA, LLC | $183.62 | 16 | $0 (2019) |
| EMD Serono, Inc. | $164.12 | 20 | $0 (2020) |
| Amarin Pharma Inc. | $118.11 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $544.99 | 33 | AstraZeneca Pharmaceuticals LP ($148.26) |
| 2021 | $1,052 | 71 | AstraZeneca Pharmaceuticals LP ($337.64) |
| 2020 | $962.08 | 65 | AstraZeneca Pharmaceuticals LP ($257.11) |
| 2019 | $991.01 | 77 | Sunovion Pharmaceuticals Inc. ($157.49) |
| 2018 | $1,190 | 83 | GlaxoSmithKline, LLC. ($278.00) |
| 2017 | $1,076 | 84 | GlaxoSmithKline, LLC. ($233.84) |
All Payment Transactions
413 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/14/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Diabetes | ||||||
| 07/13/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: Respiratory | ||||||
| 06/23/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Diabetes | ||||||
| 06/22/2022 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $11.85 | General |
| Category: Medical Device | ||||||
| 06/16/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Cardio-renal | ||||||
| 06/09/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Diabetes | ||||||
| 06/02/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/01/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/26/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Cardio-renal | ||||||
| 05/25/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Respiratory | ||||||
| 05/23/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/12/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Diabetes | ||||||
| 05/09/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Diabetes | ||||||
| 05/04/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: DIABETES | ||||||
| 04/27/2022 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $10.96 | General |
| Category: Respiratory | ||||||
| 04/20/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: Respiratory | ||||||
| 04/14/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Cardio-renal | ||||||
| 04/14/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: RESPIRATORY | ||||||
| 04/04/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/30/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Respiratory | ||||||
| 03/28/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Diabetes Care | ||||||
| 03/22/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Respiratory | ||||||
| 03/09/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Diabetes | ||||||
| 03/07/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: RESPIRATORY | ||||||
| 02/24/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 297 | 420 | $59,409 | $17,741 |
| 2021 | 13 | 793 | 1,241 | $145,353 | $64,384 |
| 2020 | 12 | 708 | 1,200 | $120,487 | $63,417 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 164 | $41,638 | $12,356 | 29.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 80 | $13,936 | $4,453 | 32.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 126 | 148 | $3,167 | $743.35 | 23.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 12 | 12 | $320.32 | $97.84 | 30.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 15 | 16 | $348.15 | $90.93 | 26.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 139 | 359 | $70,193 | $32,823 | 46.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 119 | 203 | $24,840 | $11,243 | 45.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 39 | 39 | $11,250 | $4,978 | 44.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 21 | $7,495 | $3,104 | 41.4% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 300 | 391 | $7,187 | $2,287 | 31.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 40 | 71 | $4,969 | $2,150 | 43.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 20 | 29 | $3,704 | $1,643 | 44.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 15 | 16 | $3,873 | $1,637 | 42.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 17 | 18 | $3,245 | $1,443 | 44.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $3,891 | $1,256 | 32.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 14 | 17 | $2,150 | $957.78 | 44.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 13 | $1,037 | $337.65 | 32.5% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2021 | 18 | 18 | $897.12 | $311.76 | 34.8% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 31 | 33 | $622.65 | $211.84 | 34.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 134 | 410 | $56,034 | $31,313 | 55.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 127 | 246 | $22,834 | $11,942 | 52.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 65 | 65 | $12,591 | $7,215 | 57.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 13 | 18 | $6,319 | $2,768 | 43.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 20 | 32 | $4,013 | $1,841 | 45.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 17 | 17 | $4,073 | $1,799 | 44.2% |
About Dr. Khalid Mahmoud, MD
Dr. Khalid Mahmoud, MD is a Internal Medicine healthcare provider based in Weston, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093825432.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khalid Mahmoud, MD has received a total of $5,815 in payments from pharmaceutical and medical device companies, with $544.99 received in 2022. These payments were reported across 413 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($5,783).
As a Medicare-enrolled provider, Mahmoud has provided services to 1,798 Medicare beneficiaries, totaling 2,861 services with total Medicare billing of $145,543. Data is available for 3 years (2020–2022), covering 31 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Weston, WV
- Active Since 08/30/2006
- Last Updated 11/25/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1093825432
Products in Payments
- SYMBICORT (Drug) $576.24
- TRELEGY ELLIPTA (Drug) $444.66
- Ozempic (Drug) $432.11
- BREZTRI (Drug) $383.72
- SPIRIVA RESPIMAT (Drug) $362.51
- LONHALA MAGNAIR (Drug) $242.67
- TRADJENTA (Drug) $226.74
- Victoza (Drug) $224.52
- ENTRESTO (Drug) $214.74
- BREO (Drug) $212.01
- ANORO (Drug) $183.15
- JANUVIA (Drug) $181.02
- TRULICITY (Drug) $157.65
- Vascepa (Drug) $118.11
- Mavenclad (Biological) $116.61
- BREZTRI AEROSPHERE (Drug) $111.15
- FARXIGA (Drug) $107.88
- Tresiba (Drug) $100.46
- STIOLTO (Drug) $88.84
- Kerendia (Drug) $87.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Weston
David Snipelisky, Md, MD
Internal Medicine — Payments: $190,032
Timmy Nguyen, M.d, M.D
Internal Medicine — Payments: $59,889
Fnu Asad-Ur-Rahman, M.d, M.D
Internal Medicine — Payments: $57,510
Dr. Roger Alvarez, D.o., M.p.h, D.O., M.P.H
Internal Medicine — Payments: $52,185
Shalender Bhasin, Md, MD
Internal Medicine — Payments: $35,905
Tolga Erim, D.o, D.O
Internal Medicine — Payments: $35,786